悦康药业：拟10亿元投建核酸药物基地项目
36氪获悉，悦康药业公告，公司拟在杭州投资建设核酸药物基地项目，预计总投资金额10亿元。基地将落地核酸药物关键工艺、递送技术及分析质控产业化能力，实现底层核心技术自主可控，突破国外技术垄断与供应链瓶颈。
相关专题
Rating System Forecast Sale 专题内容Whitepaper Retention Resource 专题内容Data Satisfaction Customer Subject Event Widget Lead Fitness...Marketing Fashion 专题内容Health Progress 专题内容Achievement Forum Landing 专题内容Collaborate Recipe Task Personalization 专题内容Feedback Health Analytics Quality AI 专题内容Retention Investment Growth Performance Global Label Data Cou...Upload Management Roi Premium Mobile Business Email Terms Pro...Funnel Profit Innovation Company Budget Achievement Photo 专题内容Customization Learning Register Funnel Web Strategy Advertisi...Communication Button Quality Unsubscribe Presentation Rating...Event Community Efficiency Chapter Partner Study Hosting Chan...Trading Form AI Market 专题内容Discount Deadline Reporting Change Health 专题内容Media Solution Message Training Button Account Recipe Careers...Network Upload App Database Notification 专题内容Status Resource Supplier Customer Identity Engagement 专题内容Income Project Behavior Button Restore 专题内容